Concepts (174)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Myocytes, Cardiac | 12 | 2023 | 764 | 2.490 |
Why?
|
| Cellular Reprogramming | 6 | 2023 | 189 | 1.740 |
Why?
|
| Fibroblasts | 9 | 2022 | 1682 | 1.500 |
Why?
|
| Myocardial Infarction | 7 | 2023 | 1374 | 1.360 |
Why?
|
| Cell Transdifferentiation | 5 | 2021 | 112 | 1.260 |
Why?
|
| GATA4 Transcription Factor | 4 | 2017 | 45 | 1.240 |
Why?
|
| Cellular Reprogramming Techniques | 4 | 2020 | 30 | 1.040 |
Why?
|
| T-Box Domain Proteins | 5 | 2022 | 156 | 0.920 |
Why?
|
| Endothelium | 1 | 2021 | 158 | 0.780 |
Why?
|
| Vascular Endothelial Growth Factor A | 3 | 2016 | 1533 | 0.670 |
Why?
|
| Myogenic Regulatory Factors | 2 | 2014 | 35 | 0.600 |
Why?
|
| Regeneration | 2 | 2017 | 279 | 0.590 |
Why?
|
| Gene Transfer Techniques | 3 | 2016 | 716 | 0.590 |
Why?
|
| Heart Diseases | 2 | 2023 | 732 | 0.590 |
Why?
|
| Lentivirus | 1 | 2017 | 169 | 0.580 |
Why?
|
| Fibrosis | 2 | 2017 | 793 | 0.560 |
Why?
|
| Rats | 10 | 2022 | 6086 | 0.510 |
Why?
|
| MEF2 Transcription Factors | 4 | 2017 | 47 | 0.420 |
Why?
|
| Ventricular Function | 1 | 2012 | 93 | 0.420 |
Why?
|
| Heart | 1 | 2017 | 1223 | 0.380 |
Why?
|
| Neovascularization, Physiologic | 1 | 2012 | 345 | 0.380 |
Why?
|
| Genetic Vectors | 4 | 2017 | 1694 | 0.310 |
Why?
|
| Coronary Artery Bypass | 2 | 2000 | 708 | 0.260 |
Why?
|
| Transcription Factors | 4 | 2022 | 5270 | 0.260 |
Why?
|
| Endothelial Cells | 2 | 2021 | 1048 | 0.230 |
Why?
|
| Rats, Inbred F344 | 2 | 2014 | 224 | 0.230 |
Why?
|
| Cell Differentiation | 1 | 2014 | 4078 | 0.220 |
Why?
|
| Animals | 16 | 2022 | 59536 | 0.220 |
Why?
|
| Technology | 1 | 2023 | 96 | 0.210 |
Why?
|
| Cell Plasticity | 1 | 2021 | 66 | 0.200 |
Why?
|
| Butyric Acid | 1 | 2020 | 13 | 0.190 |
Why?
|
| Myocardium | 4 | 2023 | 1313 | 0.180 |
Why?
|
| Heart Arrest, Induced | 1 | 2000 | 87 | 0.180 |
Why?
|
| Coculture Techniques | 1 | 2021 | 626 | 0.180 |
Why?
|
| Adenoviridae | 2 | 2016 | 1459 | 0.180 |
Why?
|
| Cell Separation | 1 | 2021 | 612 | 0.180 |
Why?
|
| Hemodynamics | 2 | 2000 | 935 | 0.170 |
Why?
|
| Myocardial Contraction | 1 | 2000 | 291 | 0.170 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 1 | 2020 | 204 | 0.170 |
Why?
|
| Flow Cytometry | 3 | 2021 | 3033 | 0.160 |
Why?
|
| Pyrimidinones | 1 | 2020 | 314 | 0.160 |
Why?
|
| Intraoperative Complications | 1 | 2000 | 301 | 0.160 |
Why?
|
| Tretinoin | 1 | 2020 | 623 | 0.150 |
Why?
|
| Animals, Newborn | 1 | 2021 | 1338 | 0.150 |
Why?
|
| Connective Tissue Growth Factor | 1 | 2017 | 45 | 0.150 |
Why?
|
| Snail Family Transcription Factors | 1 | 2017 | 120 | 0.150 |
Why?
|
| Fibronectins | 1 | 2017 | 197 | 0.140 |
Why?
|
| Zinc Fingers | 1 | 2017 | 205 | 0.140 |
Why?
|
| Collagen Type I | 1 | 2017 | 204 | 0.140 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2020 | 612 | 0.140 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2020 | 2063 | 0.140 |
Why?
|
| Sp1 Transcription Factor | 1 | 2016 | 188 | 0.140 |
Why?
|
| Gene Silencing | 1 | 2018 | 837 | 0.130 |
Why?
|
| Trans-Activators | 2 | 2018 | 1555 | 0.120 |
Why?
|
| Bridged Bicyclo Compounds, Heterocyclic | 1 | 2020 | 923 | 0.120 |
Why?
|
| Prevalence | 1 | 2021 | 3260 | 0.120 |
Why?
|
| Tissue Engineering | 2 | 2005 | 269 | 0.110 |
Why?
|
| Phosphoproteins | 1 | 2018 | 1152 | 0.110 |
Why?
|
| Down-Regulation | 1 | 2017 | 2074 | 0.100 |
Why?
|
| Models, Animal | 1 | 2014 | 664 | 0.100 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2017 | 1242 | 0.100 |
Why?
|
| Heart Transplantation | 2 | 1996 | 908 | 0.100 |
Why?
|
| Heart-Assist Devices | 1 | 2000 | 1171 | 0.100 |
Why?
|
| Blood Flow Velocity | 2 | 1989 | 475 | 0.100 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2012 | 1062 | 0.090 |
Why?
|
| Histones | 1 | 2017 | 1466 | 0.090 |
Why?
|
| Aorta | 2 | 1998 | 692 | 0.090 |
Why?
|
| Bioprosthesis | 2 | 1993 | 167 | 0.090 |
Why?
|
| Aortic Valve | 2 | 1992 | 581 | 0.090 |
Why?
|
| Echocardiography | 2 | 2012 | 1182 | 0.080 |
Why?
|
| Rheology | 1 | 1988 | 55 | 0.080 |
Why?
|
| Disease Models, Animal | 2 | 2016 | 7222 | 0.080 |
Why?
|
| Arteriosclerosis | 1 | 1989 | 185 | 0.080 |
Why?
|
| Leukemia | 1 | 2017 | 1635 | 0.080 |
Why?
|
| Blotting, Western | 1 | 2014 | 3536 | 0.080 |
Why?
|
| Heart Valve Prosthesis | 3 | 1993 | 386 | 0.080 |
Why?
|
| Transfection | 1 | 2012 | 2944 | 0.080 |
Why?
|
| Drug Therapy, Combination | 1 | 2012 | 2315 | 0.070 |
Why?
|
| Aortic Diseases | 1 | 1989 | 206 | 0.070 |
Why?
|
| Male | 15 | 2020 | 123000 | 0.070 |
Why?
|
| Humans | 18 | 2023 | 261506 | 0.070 |
Why?
|
| Extracellular Matrix | 2 | 2005 | 554 | 0.070 |
Why?
|
| DNA-Binding Proteins | 1 | 2017 | 4821 | 0.060 |
Why?
|
| Prostheses and Implants | 1 | 2005 | 295 | 0.060 |
Why?
|
| MicroRNAs | 1 | 2016 | 2947 | 0.060 |
Why?
|
| Epigenesis, Genetic | 2 | 2022 | 1399 | 0.050 |
Why?
|
| Alginates | 1 | 2020 | 16 | 0.050 |
Why?
|
| Cells, Cultured | 2 | 2020 | 5637 | 0.050 |
Why?
|
| Diastole | 1 | 2000 | 187 | 0.050 |
Why?
|
| Ventricular Function, Right | 1 | 2000 | 111 | 0.040 |
Why?
|
| Aortic Valve Insufficiency | 2 | 1992 | 167 | 0.040 |
Why?
|
| Signal Transduction | 1 | 2017 | 11965 | 0.040 |
Why?
|
| Anastomosis, Surgical | 1 | 2000 | 371 | 0.040 |
Why?
|
| Stroke Volume | 1 | 2000 | 577 | 0.040 |
Why?
|
| Swine | 2 | 2016 | 1541 | 0.040 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 2000 | 500 | 0.040 |
Why?
|
| Wnt Signaling Pathway | 1 | 2020 | 430 | 0.040 |
Why?
|
| Subclavian Vein | 1 | 1996 | 35 | 0.040 |
Why?
|
| Ventricular Function, Left | 1 | 2000 | 603 | 0.040 |
Why?
|
| Troponin T | 1 | 2018 | 261 | 0.030 |
Why?
|
| New Zealand | 1 | 1996 | 60 | 0.030 |
Why?
|
| Subclavian Artery | 1 | 1996 | 80 | 0.030 |
Why?
|
| RNA, Small Interfering | 1 | 2022 | 2216 | 0.030 |
Why?
|
| Aneurysm | 1 | 1996 | 94 | 0.030 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2005 | 1237 | 0.030 |
Why?
|
| Arteriovenous Fistula | 1 | 1996 | 92 | 0.030 |
Why?
|
| Gene Expression Regulation, Leukemic | 1 | 2017 | 560 | 0.030 |
Why?
|
| Blood Pressure | 1 | 2000 | 1467 | 0.030 |
Why?
|
| Waiting Lists | 1 | 1996 | 263 | 0.030 |
Why?
|
| In Vitro Techniques | 1 | 2016 | 1618 | 0.030 |
Why?
|
| Mice | 3 | 2021 | 34495 | 0.030 |
Why?
|
| Aged | 8 | 2000 | 70117 | 0.030 |
Why?
|
| Tricuspid Valve | 1 | 1993 | 68 | 0.030 |
Why?
|
| Tricuspid Valve Insufficiency | 1 | 1993 | 67 | 0.030 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2016 | 622 | 0.030 |
Why?
|
| Female | 12 | 2005 | 141928 | 0.030 |
Why?
|
| Cause of Death | 1 | 1996 | 752 | 0.030 |
Why?
|
| Membrane Proteins | 1 | 2022 | 2819 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2012 | 32848 | 0.030 |
Why?
|
| Heart Failure | 1 | 2005 | 2516 | 0.020 |
Why?
|
| Thrombosis | 1 | 1998 | 781 | 0.020 |
Why?
|
| Aortic Aneurysm, Thoracic | 1 | 1998 | 595 | 0.020 |
Why?
|
| Blood Vessel Prosthesis Implantation | 1 | 1998 | 705 | 0.020 |
Why?
|
| Middle Aged | 6 | 2000 | 86204 | 0.020 |
Why?
|
| Myosins | 1 | 1990 | 96 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2017 | 4143 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2020 | 4053 | 0.020 |
Why?
|
| Phenotype | 1 | 2020 | 6295 | 0.020 |
Why?
|
| Mathematics | 1 | 1988 | 136 | 0.020 |
Why?
|
| Leiomyosarcoma | 1 | 1990 | 223 | 0.020 |
Why?
|
| Abdominal Neoplasms | 1 | 1990 | 231 | 0.020 |
Why?
|
| Heart Block | 1 | 1987 | 48 | 0.020 |
Why?
|
| Cardiac Pacing, Artificial | 1 | 1987 | 127 | 0.020 |
Why?
|
| Aortic Valve Stenosis | 1 | 1992 | 476 | 0.020 |
Why?
|
| Mediastinal Neoplasms | 1 | 1990 | 423 | 0.020 |
Why?
|
| Materials Testing | 1 | 2005 | 116 | 0.020 |
Why?
|
| Graft Rejection | 1 | 1990 | 834 | 0.020 |
Why?
|
| Absorbable Implants | 1 | 2005 | 65 | 0.020 |
Why?
|
| Nuclear Proteins | 1 | 2016 | 3343 | 0.020 |
Why?
|
| Electrophysiologic Techniques, Cardiac | 1 | 2005 | 69 | 0.020 |
Why?
|
| Sus scrofa | 1 | 2005 | 169 | 0.020 |
Why?
|
| Polytetrafluoroethylene | 1 | 2005 | 113 | 0.020 |
Why?
|
| Biocompatible Materials | 1 | 2005 | 202 | 0.020 |
Why?
|
| Coronary Angiography | 1 | 2005 | 598 | 0.010 |
Why?
|
| Survival Rate | 1 | 1996 | 12221 | 0.010 |
Why?
|
| Urinary Bladder | 1 | 2005 | 575 | 0.010 |
Why?
|
| Time Factors | 1 | 1996 | 12926 | 0.010 |
Why?
|
| Coronary Vessels | 1 | 2005 | 665 | 0.010 |
Why?
|
| Heart Ventricles | 1 | 2005 | 846 | 0.010 |
Why?
|
| Wound Healing | 1 | 2005 | 815 | 0.010 |
Why?
|
| Adult | 4 | 1996 | 77950 | 0.010 |
Why?
|
| Risk Factors | 1 | 1996 | 17523 | 0.010 |
Why?
|
| Pericardial Effusion | 1 | 1998 | 118 | 0.010 |
Why?
|
| Angiography, Digital Subtraction | 1 | 1996 | 76 | 0.010 |
Why?
|
| Esophageal Neoplasms | 1 | 1990 | 3168 | 0.010 |
Why?
|
| Biomarkers | 1 | 2005 | 5047 | 0.010 |
Why?
|
| Endocarditis, Bacterial | 1 | 1992 | 128 | 0.010 |
Why?
|
| Macaca | 1 | 1990 | 95 | 0.010 |
Why?
|
| Heart Valve Diseases | 1 | 1992 | 193 | 0.010 |
Why?
|
| Abdominal Muscles | 1 | 1990 | 68 | 0.010 |
Why?
|
| Random Allocation | 1 | 1990 | 703 | 0.010 |
Why?
|
| Necrosis | 1 | 1990 | 580 | 0.010 |
Why?
|
| Calcinosis | 1 | 1992 | 423 | 0.010 |
Why?
|
| Sick Sinus Syndrome | 1 | 1987 | 14 | 0.000 |
Why?
|
| Tachycardia, Supraventricular | 1 | 1987 | 84 | 0.000 |
Why?
|
| Graft Survival | 1 | 1990 | 1062 | 0.000 |
Why?
|
| Heart Arrest | 1 | 1990 | 358 | 0.000 |
Why?
|
| Adolescent | 2 | 1993 | 31252 | 0.000 |
Why?
|
| Child | 2 | 1993 | 29154 | 0.000 |
Why?
|
| Age Factors | 1 | 1987 | 5377 | 0.000 |
Why?
|
| Aged, 80 and over | 1 | 1996 | 29902 | 0.000 |
Why?
|
| Infant, Newborn | 1 | 1987 | 8223 | 0.000 |
Why?
|
| Infant | 1 | 1987 | 13310 | 0.000 |
Why?
|
| Child, Preschool | 1 | 1987 | 16273 | 0.000 |
Why?
|